Shilpa Pharma Lifesciences is a leading Indian contract development and manufacturing organization (CDMO) that provides end-to-end solutions—from early development of new chemical entities (NCEs) right through commercial manufacturing of active pharmaceutical ingredients (APIs), linkers, payloads, PEGs and specialty polymers. With three manufacturing sites, state-of-the-art infrastructure (including large-scale reactors), global regulatory approvals (US FDA, EU GMP, PMDA, TGA etc.) and more than three decades of expertise, they deliver customer-centric, cost-effective, and time-efficient services while maintaining strict IP protection, data integrity and sustainable business practices.
There are no posts for this page yet.